GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells
Anti-fibrotic effect of 6-bromo-indirubin-3′-oxime (6-BIO) via regulation of activator protein-1 (AP-1) and specificity protein-1 (SP-1) transcription factors in kidney cells - ScienceDirect
6BIO | 667463-62-9 - Order from Adipogen
Soluble 3′,6-Substituted Indirubins with Enhanced Selectivity toward Glycogen Synthase Kinase -3 Alter Circadian Period | Journal of Medicinal Chemistry
6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts | Scientific Reports
The best docking pose of 6-bromo-indirubin-3' oxime (6BIO) in PDK1. | Download Scientific Diagram
GSK 3 Inhibitor IX (6-Bromoindirubin-3'-oxime) | ATP-Competitive Inhibitor | MedChemExpress
The indirubin derivative 6-bromoindirubin-3′-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference - ScienceDirect
6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts | Scientific Reports
Anti-fibrotic effect of 6-bromo-indirubin-3′-oxime (6-BIO) via regulation of activator protein-1 (AP-1) and specificity protein-1 (SP-1) transcription factors in kidney cells - ScienceDirect
The best docking pose of 6-bromo-indirubin-3' oxime (6BIO) in PDK1. | Download Scientific Diagram
GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells
Indirubin 3′-(O-oxiran-2-ylmethyl)oxime: A novel anticancer agent - ScienceDirect
GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells